Brief: CTI Biopharma Reports Fourth Quarter And Full Year 2021 Financial Results

CTI Biopharma

31/03/2022 21:24

March 31 (Reuters) - CTI Biopharma Corp  CTIC.O :
    * CTI BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.38
    * EXPECT CURRENT CASH AND CASH EQUIVALENTS WILL ENABLE TO
FUND
OPERATIONS INTO Q4 OF 2022
    * Q4 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn4800lza 
Further company coverage:  CTIC.O 

 ((Reuters.Briefs@thomsonreuters.com;))